series-a
Stage
2
Investors
About
Waypoint Bio uses AI-powered models, spatial biology, and pooled screening to engineer and optimize cell therapies, primarily targeting solid tumors.
Explore Waypoint Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.